Table 3 Adverse events and laboratory abnormality during the treatment period
| Adverse events | Clinical events (n = 10) | [n (%)] |
|---|---|---|
| Any grade | ≥Grade 3 | |
| Diarrhea | 4 (13.3) | 0 |
| Headache | 2 (6.7) | 0 |
| Bloating | 2 (6.7) | 0 |
| Fatigue | 1 (3.3) | 0 |
| ALT increased | 1 (3.3) | 0 |
| Adverse events | Clinical events (n = 10) | [n (%)] |
|---|---|---|
| Any grade | ≥Grade 3 | |
| Diarrhea | 4 (13.3) | 0 |
| Headache | 2 (6.7) | 0 |
| Bloating | 2 (6.7) | 0 |
| Fatigue | 1 (3.3) | 0 |
| ALT increased | 1 (3.3) | 0 |